UBS Raises Lam Research Price Target to $275
- Rating
- Buy
- Target
- $275
- from $255 (+8%)
- Outcome
- Reached
- on May 5, 2026

What the analyst said
UBS analyst Timothy Arcuri raised the price target on Lam Research (NASDAQ: LRCX) to $275.00 (from $255.00) while maintaining a Buy rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
LRCX trades at $185. The 9 analysts who set a target in the last 3 months range from $290 to $400, with a median of $350. This $275 target is 21% below the median, the lowest on the Street.
Since the note LRCX has moved −23% (from $240). 12-month window: day 280 of 365, closes on January 29, 2027.
Track record
This call✓ Target reached on May 5, 2026, 3 months after the note.
Firm track recordUBS: 81% of its 53 targets at least a year old were reached within 12 months (#9 of 26 firms). Accuracy ranking →
UBS on Lam Research
UBS price targets on Lam Research
8 calls from January 20, 2026 to October 22, 2026. The target went from $255 to $400 (+57%). The rating stayed Buy.
- October 22, 2026Target cut from $425 (−6%)Buy$400
- September 1, 2026Target cut from $435 (−2%)Buy$425
- July 15, 2026Target raised from $375 (+16%)Buy$435
- June 9, 2026Target raised from $310 (+21%)Buy$375
- April 23, 2026Kept the $310 targetBuy$310
- April 13, 2026Target raised from $275 (+13%)Buy$310
- January 29, 2026 This noteTarget raised from $255 (+8%)Buy$275
- January 20, 2026Earliest call shownBuy$255




